ERNA vs EXPD · P/E 0.0, rev $582.0K vs P/E 26, rev $10.60B
Eterna Therapeutics Inc (ERNA) versus Expeditors International of Washington, Inc. (EXPD) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported EXPD revenue for 2024-12-31 was $10.60B. Net income was $811.6M. Revenue was up 14.0% from 2023-12-31 to 2024-12-31. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
Not investment advice. Open the ERNA and EXPD stock pages for the full models.
Not investment advice.